Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ECO
    --Site Admin--
    • Oct 2007
    • 1360

    #1

    If you could use next-gen sequencing technology to answer any question....

    ...what small study would you do?

    This is intended as a bit of fantasy, but a serious question, as I've often considered this question:

    If you could do one small set of focused samples what would they be and what platform would you use to answer the question?

    Cost/labor/your ability to analyze the data is not to be considered...we're talking pure scientific curiousity. Let's limit it to say one run on a GA/SOLiD, or 2-3 runs on 454, or a combination of short/long reads. But no more than 8-16 samples.

    Moon rocks? Environmental mining? The fauna scraped off your windshield after a cross country drive? Swabs from a subway seat?
  • cariaso
    Member
    • Jan 2008
    • 31

    #2
    N timepoints for 3 patients from birth to death. Patients are triplets (twins+1) . The first two would be raised in the same environment, the third would be separated at birth. Sequence the epigenome. No clear platform preference.

    No triplets were harmed in the making of this fantasy.
    Last edited by cariaso; 05-07-2008, 04:01 PM.

    Comment

    • apfejes
      Senior Member
      • Feb 2008
      • 236

      #3
      I like cariaso's study, though I'd also do gene expression studies:

      I'd take N drug therapies, and test the whole transcriptome shotgun expression on each of M cell types, on X people, where N, N and X are impossibly large numbers. And, of course, each of the X people would also have a complete genome reference assembled.

      You'd be able to figure out what parts of the genome cause drug interactions (successful, no effect or adverse side effect) if M,N and X were large enough.

      For people who develop resistance, ie. cancer drugs no longer work, I'd also WTSS those tissues before and after resistance occurs to identify mechanisms.

      What fun!
      The more you know, the more you know you don't know. —Aristotle

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      15 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      41 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Working...